Research Article | Open Access
Ulrike Lodemann, Julia Strahlendorf, Peter Schierack, Shanti Klingspor, Jörg R. Aschenbach, Holger Martens, "Effects of the Probiotic Enterococcus faecium and Pathogenic Escherichia coli Strains in a Pig and Human Epithelial Intestinal Cell Model", Scientifica, vol. 2015, Article ID 235184, 10 pages, 2015. https://doi.org/10.1155/2015/235184
Effects of the Probiotic Enterococcus faecium and Pathogenic Escherichia coli Strains in a Pig and Human Epithelial Intestinal Cell Model
The aim of this study has been to elucidate the effect of the probiotic Enterococcus faecium NCIMB 10415 on epithelial integrity in intestinal epithelial cells and whether pre- and coincubation with this strain can reproducibly prevent damage induced by enterotoxigenic (ETEC) and enteropathogenic Escherichia coli (EPEC). Porcine (IPEC-J2) and human (Caco-2) intestinal epithelial cells were incubated with bacterial strains and epithelial integrity was assessed by measuring transepithelial electrical resistance (TEER) and mannitol flux rates. E. faecium alone increased TEER of Caco-2 cells without affecting mannitol fluxes whereas the E. coli strains decreased TEER and concomitantly increased mannitol flux rates in both cell lines. Preincubation with E. faecium had no effect on the TEER decrease induced by E. coli in preliminary experiments. However, in a second set of experiments using a slightly different protocol, E. faecium ameliorated the TEER decrease induced by ETEC at 4 h in IPEC-J2 and at 2, 4, and 6 h in Caco-2 cells. We conclude that E. faecium positively affected epithelial integrity in monoinfected Caco-2 cells and could ameliorate the damage on TEER induced by an ETEC strain. Reproducibility of the results is, however, limited when experiments are performed with living bacteria over longer periods.
Following the ban of antibiotic growth promoters in farm animals in the European Union in 2006, the search for alternative growth and health promoters has been intensified. Among such promoters, probiotics seem to be a suitable feed additive promoting health and performance parameters of piglets [1–3]. However, research with regard to their application in farm animals is still fragmentary and our present knowledge concerning the underlying mechanisms of the effects of probiotics is limited.
Enterococcus faecium NCIMB 10415 (E. faecium) is used as a probiotic supplement in farm animals. It has shown positive effects on diarrhoea incidence [4, 5] and daily weight gain  in pigs. Furthermore, effects on immunological parameters in the gastrointestinal tract [6–8] and effects on transport properties in the pig jejunum  have been observed.
The mechanisms of these effects are still not well understood. For a better understanding of the interaction between intestinal cells and probiotics, cell models can be used, as done with human probiotic preparations [10–12].
Therefore, we have examined the effects of E. faecium in a model of porcine intestinal epithelial cells, namely, in IPEC-J2 cells isolated from the jejunum of a newborn piglet [13, 14]. Their usefulness as a model for studies of microbial pathogenesis in pigs has previously been assessed . Up to now, these cells have been used in probiotic studies with different strains, including assessments of the adhesion capability of various probiotic strains such as Lactobacillus plantarum, Enterococcus faecium EF2019, and Saccharomyces cerevisiae [16–19] and of the capability of probiotics to inhibit inflammatory responses [18, 20] or their antiviral activity .
In the present study, we have focused on the barrier function of the epithelial cells. We have compared a human cell line, namely, Caco-2, an established in vitro model of small intestinal mucosa, and a porcine cell culture model, namely, IPEC-J2, with regard to their response to incubation with probiotic E. faecium and pathogenic Escherichia coli strains. We have addressed the question as to whether E. faecium and two selected pathogenic E. coli strains affect the barrier function of porcine intestinal epithelial cells. Furthermore, we assumed that the effects of pathogenic strains can be modified by E. faecium. In the performed experiments, intestinal epithelial cells were incubated long-term with live bacteria.
2. Materials and Methods
2.1. Cells and Culture Conditions
The porcine intestinal epithelial cell line (IPEC-J2) was established from the jejunum of a newborn piglet [13, 14] and kindly provided by Professor Anthony Blikslager (North Carolina State University, USA). The IPEC-J2 cells were maintained in Dulbecco’s modified Eagle medium (DMEM)/Ham’s F-12 medium (1 : 1), supplemented with 5% fetal bovine serum (FBS, Biochrom, Berlin, Germany), 2.5 mmol/L L-glutamine (Biochrom, Berlin, Germany), insulin (5 μg/mL), transferrin (5 μg/mL), selenium (5 ng/mL) (ITS, Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany), epidermal growth factor (EGF, 5 ng/mL, Biochrom, Berlin, Germany), and penicillin-streptomycin (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). IPEC-J2 cells were passaged by trypsinization (0.15 g/L porcine trypsin, 0.06 g/L EDTA, Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). Cells were used consistently within 14 days from the seeding of passages 69–79.
Human epithelial intestinal cells from colorectal adenocarcinoma, Caco-2 (ATCC Catalog number HTB-37, ATCC, Manassas, USA) were maintained in Eagle’s minimum essential medium with Earle’s BSS and 2 mmol/L L-glutamine (EMEM, LGC Standards GmbH, Wesel, Germany) modified by ATCC to contain 1.0 mmol/L sodium pyruvate, 0.1 mmol/L nonessential amino acids, 1.5 g/L sodium bicarbonate, and supplemented with 20% FBS and penicillin-streptomycin. Cells were studied between passages 33 and 46 and subcultured every 4-5 days, after trypsin treatment (2.5 g/L porcine trypsin and 0.2 g/L EDTA, Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany).
Both cell lines were grown at 37°C in a humidified atmosphere of 5% CO2. Cell cultures were routinely tested and found to be free of mycoplasma contamination. On the day prior to experiments, the cells were fed with serum- and antibiotic-free medium.
2.2. Transepithelial Electrical Resistance (TEER) Measurements
For TEER, mannitol, and pH measurements, the cells were seeded on clear polyester membrane cell culture inserts (Snapwell, 12 mm diameter, 1.12 cm2 area, 0.4 μm pore size; Corning B.V., Schiphol-Rijk, Netherlands). The membranes were coated with rat tail collagen type I (Serva Electrophoresis GmbH, Heidelberg, Germany) for IPEC-J2 cells. Cells were seeded at a density of 105 cells/1.12 cm2 and were allowed to differentiate for 14 days (IPEC-J2) or 21 days (Caco-2). TEER measurements were performed by using a Millicell-ERS (Electrical Resistance System; Millipore GmbH, Schwalbach, Germany). TEER values were corrected for the resistance of blank filters and for the membrane area. Measurements were started after the cell monolayers had reached confluency.
2.3. Bacterial Strains
Cells were incubated with bacteria from the (1) probiotic strain Enterococcus faecium NCIMB 10415 (cultivated from Cylactin; Cerbios-Pharma, Barbengo, Switzerland, and provided by David Taras, Institute of Animal Nutrition, Berlin, Germany), (2) enterotoxigenic E. coli IMT4818 (ETEC, isolated from a two week-old piglet with enteritis, O149:K91:K88 (F4) and found to be positive for the presence of virulence genes est-1a, est-2 (genes coding for heat stable enterotoxins I and II), and elt-1a/b (gene coding for heat labile enterotoxin I) by polymerase chain reaction (PCR)), or (3) human enteropathogenic E. coli E2348/69 (EPEC, serotype O127:H6 and positive for eae (E. coli attaching-effacing) gene).
E. faecium NCIMB 10415 was grown in brain-heart infusion (BHI) broth (OXOID GmbH, Wesel, Germany) and the ETEC and EPEC strains were grown in LB medium containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl, at a pH of 7.0. Tryptone and the yeast extract were from OXOID.
After overnight incubation at 37°C, subcultures of bacteria grown for ~3 h until midlog phase were centrifuged and washed twice in phosphate-buffered saline (PBS, Biochrom, Berlin, Germany). Bacterial cells were then resuspended in antibiotic- and serum-free IPEC-J2 or Caco-2 cell culture medium at a concentration of ~108 colony-forming units (CFU)/mL. From this solution, aliquots were added to the apical compartment of the cell culture inserts, which contains 0.5 mL media, to reach the concentrations indicated below.
Bacterial concentration was determined by measuring the optical density and confirmed by serial dilution followed by determining viable counts on agar plates (Columbia blood agar, PC agar for all strains, Endo agar for E. coli strains, and Citrate Azide Tween Carbonate Agar for E. faecium) in preliminary experiments. Cells were infected with 106, 107 and, for the E. faecium strain, also with 5 × 106 bacteria per cell culture insert (1.12 cm2), corresponding to a multiplicity of infection (MOI) of 10, 50, and 100 bacteria, respectively, per seeded cell. When the cells were infected with E. faecium and either the ETEC or the EPEC together, cells were preincubated with E. faecium for 3 h in the first set of experiments and for 2 h in the second set of experiments and, after that, the pathogenic E. coli strains were added. The cells were in contact with the E. coli for the same duration as in the monoincubation monolayers with either ETEC or EPEC. This setup will be called “coincubation” in the following and the incubation time will be given as the time that the cells were incubated with the pathogenic E. coli strains.
2.4. Measurements of 3H-Mannitol Fluxes
Flux rates of mannitol were measured by using D-[1-3H]-mannitol (PerkinElmer Life Sciences, Rodgau-Jügesheim, Germany). The isotope (0.3 μCi) was added to the apical side of the cell monolayers, and the cells were incubated for 30 min to allow equilibration of the isotope. Fluxes were calculated from the rate of appearance of tracer on the serosal side of the cell monolayer within 60 min (three fluxes of 20 min). D-[1-3H]-Mannitol was assayed by using a well-type crystal β-counter (LKB Wallace-PerkinElmer, Überlingen, Germany).
2.5. pH Measurements
The pH of cell culture media at the apical side of the cell monolayers was measured with an InLab Surface electrode (Mettler Toledo Online GmbH, Nänikon, Switzerland) connected to a pH meter (inoLab pH 720, Wissenschaftlich-Technische Werkstätten GmbH, Weilheim, Germany).
2.6. Statistical Analysis
Statistical evaluations were carried out by means of the PASW Statistics program for Windows, version 18 (Jandel, Chicago, IL, USA). Graphs were plotted with Excel 2010. Unless otherwise stated, results are given as mean ± standard error of the mean. The number of cell monolayers that entered the statistical evaluation is indicated in the relevant tables and figure legends. Results were considered to be significant at ≤ 0.05.
To assess the effect of the various numbers of bacteria (“dose”) on TEER, a one-way analysis of variance with the fixed factor “dose” (0, 106, 5 × 106, 107/1.12 cm2 or 0, 106, 107/1.12 cm2), was conducted per time point (h) with a post hoc Scheffe test. For effects of incubation with E. faecium on TEER, a one-way analysis of variance with the fixed factor “treatment” (control, E. faecium) was conducted per time point. For effects of bacterial incubation and preincubation with E. faecium on TEER, a one-way analysis of variance with the fixed factor “treatment” (control: E. faecium, ETEC, and E. faecium + ETEC; control: E. faecium, EPEC, and E. faecium + EPEC) was conducted per time point with a post hoc Scheffe or LSD (least significant difference) test.
3.1. Determination of the Incubation Conditions
TEER reached values of ~5000 Ohm × cm2 in confluent IPEC-J2 cell monolayers after 14 days in culture and ~550 Ohm × cm2 in Caco-2 cells after 21 days. Next, we optimized the incubation conditions for the infection model by testing various dosages of the E. faecium (106, 5 × 106, and 107 CFU/cell culture inserts) and the two pathogenic E. coli strains (106 and 107 CFU/cell culture inserts).
Changes of TEER were measured over 12 h in IPEC-J2 cells after mucosal addition of bacterial strains (Figure 1). When the cell monolayers were exposed to increasing doses of E. faecium, the TEER values showed no significant differences (Figure 1(a)). In contrast, in IPEC-J2 cell monolayers incubated with the ETEC strain, the highest infection dose induced a significant decrease in TEER beginning at 4 h and reaching values of ~20% of the initial value after 6 h (Figure 1(b)). When the IPEC-J2 cells were incubated with EPEC, the TEER was significantly decreased compared with the control from 6 or 8 h onwards at the highest and the lower infection doses, respectively (Figure 1(c)).
In Caco-2 cells, the highest dose of E. faecium induced a decrease in TEER after 24 h (Figure 2(a)).
When the Caco-2 cells were incubated with ETEC, the TEER decreased in a concentration-dependent manner starting already at 2 h (Figure 2(b)). In contrast, when infected with EPEC, the TEER did not significantly differ from the control group until 8 h (Figure 2(c)). Thereafter, a decrease was observed at the highest infection dose and, after 12 h, also at the lower infection dose.
In some of the experiments, mannitol flux rates were measured, as a marker of paracellular permeability, in parallel to the measurement of TEER (see Tables 1 and 2). The mannitol flux rates reflected the changes in TEER.
|Bacterial strains: IPEC-J2 cells were incubated with E. faecium (Ecf), ETEC, or EPEC for 4 h and 8 h (mean ± standard deviation, variance analysis, post hoc Scheffe test, , and different letters indicate significant differences between incubation groups); = cell culture inserts.|
|Bacterial strains: Caco-2 cells were incubated with E. faecium (Ecf), ETEC, or EPEC for 10 h (mean ± standard deviation, variance analysis, post hoc Scheffe test, , different letters indicate significant differences between incubation groups); = cell culture inserts.|
3.2. Effects of the Probiotic E. faecium on TEER
We chose an E. faecium concentration of 106 bacteria/1.12 cm2 for all further experiments and observed an enhancing effect on TEER over 12 h in Caco-2 cell monolayers, which was significant from 6 h to 10 h (Figure 3(b)). No such effect was observed in IPEC-J2 cell monolayers. Instead, the TEER of IPEC-J2 cell monolayers incubated with E. faecium significantly decreased from 8 h onwards in this experimental series (Figure 3(a)).
3.3. Effects of Coincubation with E. faecium on Pathogenic Challenge in a First Series of Experiments
As we were interested in whether the effects of a pathogenic challenge by the E. coli strains could be prevented by the probiotic E. faecium, we preincubated the epithelial cells for 3 h with E. faecium, after which time the pathogenic E. coli strains were added. In parallel, cell monolayers were monoinfected with the respective strains, the incubation lasted for 12 h (IPEC-J2) and 24 h (Caco-2), respectively. In both cell lines, E. faecium did not reproducibly delay the decrease in TEER induced by ETEC and EPEC (data not shown).
The pH in cell culture inserts was measured at the apical side of the cell monolayer. For IPEC-J2 cells, the pH values decreased with time and were below 6.5 after 10 h of incubation with EPEC and the E. faecium coincubation with ETEC and EPEC. The pH of Caco-2 cell media decreased below 7 after 10 h for the E. coli strains and their coincubations (data not shown).
3.4. Effects of Coincubation with E. faecium on Pathogenic Challenge in a Second Set of Experiments
Based on the results of the first set of experiments, we conducted a further set of experiments with shorter incubation times. In these experiments, only the effects of ETEC were tested, taking care to exactly match the duration of incubation of cells with the pathogenic E. coli in both monoinfected and coincubated cells. In these experiments, the coincubation with E. faecium could ameliorate the decrease in TEER induced by ETEC at 4 h in IPEC-J2 and at 2, 4, and 6 h in Caco-2 cells (see Figure 4).
Probiotic feed supplementation is an alternative for the use of antibiotic growth promoters in farm animals that is now prohibited in the EU. E. faecium NCIMB 10415 is accredited as a feed supplement for piglets and has positive effects on health incidence and performance parameters [4, 5], which cannot be satisfactorily explained on the basis of our present knowledge. The possible improvement or protection of the intestinal barrier function has been discussed as one possible mechanism of probiotic action [11, 12]. The present study has been undertaken to determine the validity of these arguments. The effects of E. faecium and two selected pathogenic bacterial E. coli strains on TEER of IPEC-J2 (pig) and Caco-2 (human) cell monolayers have been investigated. Of particular interest was the potential beneficial effect of E. faecium on the barrier integrity of the IPEC-J2 cell line, because studies regarding the complete or partial abrogation of the impairing effects of pathogenic E. coli by probiotics have mostly been conducted with human cell lines and probiotics used in human nutrition [22–26].
4.1. Experimental Model
We used live bacteria in our study, because various cell structures or secreted factors, such as bacterial DNA, secreted substances, and cell wall components, might be responsible for any effects induced. The infection model proved difficult to handle because the time course of the change in TEER after addition of bacteria differed between experiments conducted on different days. The latter occurred despite due care to have a highly standardized procedure and may point to the fact that even minor differences in cell passages and batches of bacterial culture may have huge impacts on the experimental outcome. An overall statistical evaluation of the results of multiple independent experiments was therefore difficult. In addition, we used live bacteria over a long period of time, during which they multiplied in the cell culture wells. This had effects on the pH of the cell culture media which declined and hence the data from later time points could have been influenced by the change in pH. We therefore reduced the duration of the incubation time when we tested the probiotic effect on changes induced by ETEC in a second set of coculture experiments.
4.2. Effects of E. faecium Per Se on TEER
TEER is measured as a parameter to assess the variation of the integrity and permeability of the epithelial barrier [27–29] and is given by the cellular resistance, , and the shunt resistance, , which operate in parallel. Any change of TEER can be caused by changes of , , or both.
The E. faecium strain had either no effect on TEER or resulted in a decrease in the TEER in IPEC-J2 cells from 8 h of incubation onwards. In Caco-2 cells, the TEER was increased by E. faecium at a concentration of 106/1.12 cm2. The latter findings are in general agreement with results from other probiotics (Bifidobacterium infantis, E. coli Nissle 1917, Lactobacillus acidophilus, Streptococcus thermophilus, VSL#3, L. rhamnosus, and Saccharomyces boulardii) and cell lines (T84, HT29/cl.19A, and Caco-2) [30–34]. The application of probiotics alone, without a pathophysiological challenge, in in vitro studies with intestinal epithelia has either an enhancing effect [30–32] or no effect on TEER [26, 33, 34], with the effect being dose- and time-dependent [31, 35, 36].
4.3. Effect of E. faecium during Pathogenic Challenge
We furthermore hypothesised that E. faecium could prevent decreases in TEER in a pathophysiological challenge. Therefore, we chose two pathogenic E. coli strains, one isolated from pig and the other from human, that decreased TEER in a time- and dose-dependent manner specific to the bacteria and their mode of action and cell lines used. This decreasing effect on TEER confirmed results of similar experiments with different cell lines, bacteria, or infection doses. A TEER decrease by E. coli O149K91 (F4 (K88ac) (ETEC) with heat labile (LT+) and heat stable (STb+) enterotoxins) in IPEC-J2 cells has also been observed by Geens and Niewold  at MOI of 10 : 1 (to 2% of the initial value after 4 h). Similar results have been reported for Caco-2 cells in the study of Roselli et al.  in which the TEER fell to about 50% after 3 h (5 × 107 bacteria/1.12 cm2). This disruption of barrier function by ETEC might in part be attributable to lipopolysaccharide or bacterial metabolites .
In Caco-2 cells incubated with EPEC (EPEC O127:H6, E2348/69), the TEER fell below 50% at 4 h in the study of Anderson et al. . The decrease in TEER after incubation with EPEC is a result of the disruption of tight junction integrity by two type III secreted effector molecules and a bacterial surface protein (Dean and Kenny, 2004, and Hecht, 2001). It is also possible that induction of enterocyte apoptosis contributes partly to the TEER increase after EPEC exposure. However, it has been previously shown that changes in epithelial resistance can occur independent of the induction of epithelial cell apoptosis, at least, in Caco-2 cells .
The effects on TEER were reflected by the changes in the mannitol flux rates as a marker for paracellular permeability. The decrease in TEER and concomitant increase in mannitol flux in response to the pathogenic E. coli strains commonly point to an opening of the paracellular permeation pathway and could be due to a change or delocalization of TJ or cytoskeletal proteins. Probiotic bacteria such as L. plantarum, L. acidophilus, or L. rhamnosus have previously been shown to prevent these effects of E. coli on barrier function in studies with Caco-2 or T84 cells [33, 39]. For example, L. sobrius DSM 16698 protected IPEC-1 cells (derived from porcine jejunum and ileum) from the disruption of TJ structure by inhibiting the delocalization of ZO-1, the reduction in the amount of occludin, the rearrangement of F-actin, and the dephosphorylation of occludin caused by an enterotoxigenic E. coli strain . This has also been shown in animal studies in vivo; for example, one week of pretreatment with L. plantarum in the drinking water abolished the E. coli-induced increase of mannitol passage in the small intestine of rats .
The ETEC and EPEC strains have been used in the current study as a pathogenic challenge to examine whether the decrease observed in TEER can be prevented or reduced by the probiotic E. faecium. The cell lines were preincubated with the probiotic before the application of ETEC or EPEC. This design was chosen based on the observation that in most of the studies in which pathogens or other damaging agents have been employed, only pretreatment with the probiotic has produced the designated effect [22, 33]. Preincubation with E. faecium did not diminish the effects of the pathogenic strains ETEC and EPEC in preliminary experiments but diminished the TEER decrease induced by ETEC in the second set of experiments.
As discussed above, the decrease in TEER induced by pathogenic E. coli strains was different on several days and in the preliminary challenge experiments the decrease in TEER started later. Furthermore, we used different preincubation times (3 h and 2 h) with the probiotic strain before the pathogenic strain was added.
Although the main effects towards incubation with bacteria were rather similar, some differences between the two cell lines could be observed. When the cells were incubated with ETEC strain, Caco-2 cells reacted earlier with a decrease in TEER and at lower bacterial concentrations (MOI 10) than IPEC-J2 cells (Figures 1, 2, and 4). Oppositely, the decrease in TEER induced by EPEC occurred generally later than that observed after addition of ETEC, with IPEC-J2 cells reacting slightly earlier. The ETEC strain was isolated from a piglet and the EPEC strain is a human strain and it might be speculated that the IPEC-J2 cells might be more adapted to the porcine pathogen. Besides species differences, the differences between the cells might also be due to their origin (tumorous or nontumouros tissues) and might also be influenced by the cell-specific media (e.g., regarding buffering capacity). As stated by Geens and Niewold  IPEC-J2 may represent a better model of normal intestinal epithelial cells than transformed cell lines because they maintain their differentiated characteristics and exhibit strong similarities to primary intestinal epithelial cells.
The increasing application of probiotics in animal nutrition requires an investigation of the underlying mechanisms of their health-promoting effects. E. faecium NCIMB 10415, which has been accredited for piglet nutrition, induces an increase in TEER in human epithelial cell monolayers, but not in the porcine intestinal cell model. Pre- and coincubation with E. faecium could ameliorate the decrease in TEER induced by enterotoxigenic E. coli. However, the effects of the probiotic strain in pathogenic challenges differed in two experimental setups and for further experiments shorter incubation times should be used.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
The authors thank Dr. G. Arndt for statistical advice and the members of the research group FOR 438. This work was supported by the Deutsche Forschungsgemeinschaft, Grant FOR 438 and SFB 852/1.
- S. C. Kyriakis, V. K. Tsiloyiannis, J. Vlemmas et al., “The effect of probiotic LSP 122 on the control of post-weaning diarrhoea syndrome of piglets,” Research in Veterinary Science, vol. 67, no. 3, pp. 223–228, 1999.
- C. Alexopoulos, A. Karagiannidis, S. K. Kritas, C. Boscos, I. E. Georgoulakis, and S. C. Kyriakis, “Field Evaluation of a Bioregulator Containing Live Bacillus cereus Spores on Health Status and Performance of Sows and their Litters,” Journal of Veterinary Medicine, Series A: Physiology Pathology Clinical Medicine, vol. 48, no. 3, pp. 137–145, 2001.
- M. Kirchgessner, F. X. Roth, U. Eidelsburger, and B. Gedek, “The nutritive efficiency of Bacillus cereus as a probiotic in the raising of piglets. 1. Effect on the growth parameters and gastrointestinal environment,” Archiv für Tierernährung, vol. 44, no. 2, pp. 111–121, 1993.
- D. Taras, W. Vahjen, M. Macha, and O. Simon, “Performance, diarrhea incidence, and occurrence of Escherichia coli virulence genes during long-term administration of a probiotic Enterococcus faecium strain to sows and piglets,” Journal of Animal Science, vol. 84, no. 3, pp. 608–617, 2006.
- A. Zeyner and E. Boldt, “Effects of a probiotic Enterococcus faecium strain supplemented from birth to weaning on diarrhoea patterns and performance of piglets,” Journal of Animal Physiology and Animal Nutrition, vol. 90, no. 1-2, pp. 25–31, 2006.
- L. Scharek, J. Guth, K. Reiter et al., “Influence of a probiotic Enterococcus faecium strain on development of the immune system of sows and piglets,” Veterinary Immunology and Immunopathology, vol. 105, no. 1-2, pp. 151–161, 2005.
- L. Scharek, J. Guth, M. Filter, and M. F. G. Schmidt, “Impact of the probiotic bacteria Enterococcus faecium NCIMB 10415 (SF68) and Bacillus cereus var. toyoi NCIMB 40112 on the development of serum IgG and faecal IgA of sows and their piglets,” Archives of Animal Nutrition, vol. 61, no. 4, pp. 223–234, 2007.
- L. J. Broom, H. M. Miller, K. G. Kerr, and J. S. Knapp, “Effects of zinc oxide and Enterococcus faecium SF68 dietary supplementation on the performance, intestinal microbiota and immune status of weaned piglets,” Research in Veterinary Science, vol. 80, no. 1, pp. 45–54, 2006.
- U. Lodemann, K. Hübener, N. Jansen, and H. Martens, “Effects of Enterococcus faecium NCIMB 10415 as probiotic supplement on intestinal transport and barrier function of piglets,” Archives of Animal Nutrition, vol. 60, no. 1, pp. 35–48, 2006.
- D. Czerucka, I. Roux, and P. Rampal, “Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells,” Gastroenterology, vol. 106, no. 1, pp. 65–72, 1994.
- A. A. Zyrek, C. Cichon, S. Helms, C. Enders, U. Sonnenborn, and M. A. Schmidt, “Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair,” Cellular Microbiology, vol. 9, no. 3, pp. 804–816, 2007.
- S. Dahan, G. Dalmasso, V. Imbert, J.-F. Peyron, P. Rampal, and D. Czerucka, “Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells,” Infection and Immunity, vol. 71, no. 2, pp. 766–773, 2003.
- H. M. Kandil, R. A. Argenzio, W. Chen et al., “L-glutamine and L-asparagine stimulate ODC activity and proliferation in a porcine jejunal enterocyte line,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 269, no. 4, part 1, pp. G591–G599, 1995.
- J. M. Rhoads, W. Chen, P. Chu, H. M. Berschneider, R. A. Argenzio, and A. M. Paradiso, “L-Glutamine and L-asparagine stimulate Na+-H+ exchange in porcine jejunal enterocytes,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 266, no. 5, pp. G828–G838, 1994.
- P. Schierack, M. Nordhoff, M. Pollmann et al., “Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine,” Histochemistry and Cell Biology, vol. 125, no. 3, pp. 293–305, 2006.
- M. Marciňáková, T. D. Klingberg, A. Lauková, and B. B. Budde, “The effect of pH, bile and calcium on the adhesion ability of probiotic enterococci of animal origin to the porcine jejunal epithelial cell line IPEC-J2,” Anaerobe, vol. 16, no. 2, pp. 120–124, 2010.
- A. Bevilacqua, C. Altieri, M. R. Corbo, M. Sinigaglia, and L. I. I. Ouoba, “Characterization of lactic acid bacteria isolated from italian bella di cerignola table olives: selection of potential multifunctional starter cultures,” Journal of Food Science, vol. 75, no. 8, pp. M536–M544, 2010.
- A. van der Aa Kühle, K. Skovgaard, and L. Jespersen, “In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains,” International Journal of Food Microbiology, vol. 101, no. 1, pp. 29–39, 2005.
- P. Schierack, S. Kleta, K. Tedin et al., “E. coli Nissle 1917 affects Salmonella adhesion to porcine intestinal epithelial cells,” PLoS ONE, vol. 6, no. 2, Article ID e14712, 2011.
- K. A. Skjolaas, T. E. Burkey, S. S. Dritz, and J. E. Minton, “Effects of Salmonella enterica serovar Typhimurium, or serovar Choleraesuis, Lactobacillus reuteri and Bacillus licheniformis on chemokine and cytokine expression in the swine jejunal epithelial cell line, IPEC-J2,” Veterinary Immunology and Immunopathology, vol. 115, no. 3-4, pp. 299–308, 2007.
- T. Botić, T. D. Klingberg, H. Weingartl, and A. Cencič, “A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria,” International Journal of Food Microbiology, vol. 115, no. 2, pp. 227–234, 2007.
- S. Michail and F. Abernathy, “Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection,” Journal of Pediatric Gastroenterology and Nutrition, vol. 35, no. 3, pp. 350–355, 2002.
- N. Parassol, M. Freitas, K. Thoreux, G. Dalmasso, R. Bourdet-Sicard, and P. Rampal, “Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells,” Research in Microbiology, vol. 156, no. 2, pp. 256–262, 2005.
- P. Varma, K. R. Dinesh, K. K. Menon, and R. Biswas, “Lactobacillus fermentum isolated from human colonic mucosal biopsy inhibits the growth and adhesion of enteric and foodborne pathogens,” Journal of Food Science, vol. 75, no. 9, pp. M546–M551, 2010.
- H. Putaala, R. Barrangou, G. J. Leyer et al., “Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli,” Beneficial Microbes, vol. 1, no. 3, pp. 283–295, 2010.
- S. RestaLenert and K. E. Barrett, “Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2,” Gastroenterology, vol. 122, no. 4, pp. 1070–1087, 2002.
- G. Wilson, I. F. Hassan, C. J. Dix et al., “Transport and permeability properties of human Caco-2 cells: an in vitro model of the intestinal epithelial cell barrier,” Journal of Controlled Release, vol. 11, no. 1–3, pp. 25–40, 1990.
- I. J. Hidalgo, T. J. Raub, and R. T. Borchardt, “Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability,” Gastroenterology, vol. 96, no. 3, pp. 736–749, 1989.
- C. H. von Bonsdorff, S. D. Fuller, and K. Simons, “Apical and basolateral endocytosis in Madin-Darby canine kidney (MDCK) cells grown on nitrocellulose filters.,” The EMBO Journal, vol. 4, no. 11, pp. 2781–2792, 1985.
- J. B. Ewaschuk, H. Diaz, L. Meddings et al., “Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 295, no. 5, pp. G1025–G1034, 2008.
- J.-M. Otte and D. K. Podolsky, “Functional modulation of enterocytes by gram-positive and gram-negative microorganisms,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 286, no. 4, pp. G613–G626, 2004.
- S. Resta-Lenert and K. E. Barrett, “Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC),” Gut, vol. 52, no. 7, pp. 988–997, 2003.
- P. M. Sherman, K. C. Johnson-Henry, H. P. Yeung, P. S. C. Ngo, J. Goulet, and T. A. Tompkins, “Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements,” Infection and Immunity, vol. 73, no. 8, pp. 5183–5188, 2005.
- D. Czerucka, S. Dahan, B. Mograbi, B. Rossi, and P. Rampal, “Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells,” Infection and Immunity, vol. 68, no. 10, pp. 5998–6004, 2000.
- T. D. Klingberg, M. H. Pedersen, A. Cencic, and B. B. Budde, “Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity,” Applied and Environmental Microbiology, vol. 71, no. 11, pp. 7528–7530, 2005.
- K. Madsen, A. Cornish, P. Soper et al., “Probiotic bacteria enhance murine and human intestinal epithelial barrier function,” Gastroenterology, vol. 121, no. 3, pp. 580–591, 2001.
- M. M. Geens and T. A. Niewold, “Preliminary characterization of the transcriptional response of the porcine intestinal cell line IPEC-J2 to enterotoxigenic escherichia coli, escherichia coli, and E. coli lipopolysaccharide,” Comparative and Functional Genomics, vol. 2010, Article ID 469583, 2010.
- M. Roselli, A. Finamore, I. Garaguso, M. S. Britti, and E. Mengheri, “Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli,” Journal of Nutrition, vol. 133, no. 12, pp. 4077–4082, 2003.
- R. C. Anderson, A. L. Cookson, W. C. McNabb, W. J. Kelly, and N. C. Roy, “Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function,” FEMS Microbiology Letters, vol. 309, no. 2, pp. 184–192, 2010.
- J. L. Roxas, A. Koutsouris, and V. K. Viswanathan, “Enteropathogenic Escherichia coli-induced epidermal growth factor receptor activation contributes to physiological alterations in intestinal epithelial cells,” Infection and immunity, vol. 75, no. 5, pp. 2316–2324, 2007.
- M. Roselli, A. Finamore, M. S. Britti et al., “The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage,” Journal of Nutrition, vol. 137, no. 12, pp. 2709–2716, 2007.
- P. Mangell, P. Nejdfors, M. Wang et al., “Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability,” Digestive Diseases and Sciences, vol. 47, no. 3, pp. 511–516, 2002.
- M. M. Geens and T. A. Niewold, “Optimizing culture conditions of a porcine epithelial cell line IPEC-J2 through a histological and physiological characterization,” Cytotechnology, vol. 63, no. 4, pp. 415–423, 2011.
Copyright © 2015 Ulrike Lodemann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.